NCT05968417View on ClinicalTrials.gov

Myeloma Novel Drug Discovery Ver 1.2

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

February 28, 2033

Study Completion Date

February 28, 2035

Conditions
Multiple Myeloma
Interventions
OTHER

Observational study - sample collection only.

No intervention - blood and/or bone marrow sample collection only

Trial Locations (1)

SM25PT

RECRUITING

The Royal Marsden NHS Foundation Trust, Sutton

All Listed Sponsors
collaborator

Royal Marsden NHS Foundation Trust

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER